Lista de obras -

11C-Choline PET/pathology image coregistration in primary localized prostate cancer

artículo científico publicado en 2014

Categorical versus continuous circulating tumor cell enumeration as early surrogate marker for therapy response and prognosis during docetaxel therapy in metastatic prostate cancer patients

artículo científico publicado en 2015

Comparison of [(11)C]Choline ([(11)C]CHO) and [(18)F]Bombesin (BAY 86-4367) as Imaging Probes for Prostate Cancer in a PC-3 Prostate Cancer Xenograft Model.

artículo científico publicado en 2015

Comparison of [¹¹C]choline ([¹¹C]CHO) and S(+)-β-methyl-[¹¹C]choline ([¹¹C]SMC) as imaging probes for prostate cancer in a PC-3 prostate cancer xenograft model

artículo científico publicado en 2015

Comparison of different SUV-based methods for response prediction to neoadjuvant radiochemotherapy in locally advanced rectal cancer by FDG-PET and MRI.

artículo científico publicado en 2011

Comparison of integrated whole-body [11C]choline PET/MR with PET/CT in patients with prostate cancer

artículo científico publicado en 2013

Detection of circulating tumor cells in different stages of prostate cancer

artículo científico publicado en 2013

Diagnostic Efficacy of (68)Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate Cancer

artículo científico publicado en 2015

Diagnostic value of retrospective PET-MRI fusion in head-and-neck cancer

artículo científico publicado en 2014

Discrimination Between Brown and White Adipose Tissue Using a 2-Point Dixon Water-Fat Separation Method in Simultaneous PET/MRI.

artículo científico publicado en 2015

Effective long-term treatment with bevacizumab for relapsed glioblastoma: case report and review of the literature

artículo científico publicado en 2014

Evaluation of feasibility and image quality of 68Ga-DOTATOC positron emission tomography/magnetic resonance in comparison with positron emission tomography/computed tomography in patients with neuroendocrine tumors

artículo científico publicado en 2013

Evaluation of the SUV values calculation and 4D PET integration in the radiotherapy treatment planning system ⬇️

artículo científico publicado el 4 de febrero de 2011

FDG PET and PET/CT ⬇️

artículo científico publicado el 1 de enero de 2013

First clinical experience with integrated whole-body PET/MR: comparison to PET/CT in patients with oncologic diagnoses

artículo científico publicado en 2012

Hypoxia imaging with FAZA-PET and theoretical considerations with regard to dose painting for individualization of radiotherapy in patients with head and neck cancer

artículo científico

Imaging gastric cancer with PET and the radiotracers 18F-FLT and 18F-FDG: a comparative analysis

artículo científico publicado en 2007

Imaging in situ breast carcinoma (with or without an invasive component) with technetium-99m pentavalent dimercaptosuccinic acid and technetium-99m 2-methoxy isobutyl isonitrile scintimammography

artículo científico publicado en 2005

Imaging of prostate cancer with PET/CT and radioactively labeled choline derivates ⬇️

artículo científico publicado el 8 de marzo de 2011

Melanoma metastases to palatine tonsils obscured by physiological FDG uptake on PET/CT.

artículo científico publicado en 2010

Motion correction strategies for integrated PET/MR.

artículo científico publicado en 2015

Non-invasive assessment of inter-and intrapatient variability of integrin expression in metastasized prostate cancer by PET.

artículo científico publicado en 2016

Non-invasive imaging of cardiac transgene expression with PET: comparison of the human sodium/iodide symporter gene and HSV1-tk as the reporter gene

artículo científico publicado en 2005

PET-MRI fusion in head-and-neck oncology: current status and implications for hybrid PET/MRI.

scientific article published on 20 May 2011

PET/MR imaging in the detection and characterization of pulmonary lesions: technical and diagnostic evaluation in comparison to PET/CT.

artículo científico publicado en 2014

PET/MR in Oncology: Non-18F-FDG Tracers for Routine Applications

artículo científico

PET/MR in prostate cancer: technical aspects and potential diagnostic value

artículo científico publicado en 2013

Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions

artículo científico publicado en 2013

Pretreatment 18F-FAZA PET predicts success of hypoxia-directed radiochemotherapy using tirapazamine

artículo científico publicado en 2007

Prognostic value of 11C-choline PET/CT and CT for predicting survival of bladder cancer patients treated with radical cystectomy

artículo científico publicado en 2014

Prognostic value of [18F]-fluoro-deoxy-glucose PET/CT, S100 or MIA for assessment of cancer-associated mortality in patients with high risk melanoma.

artículo científico publicado en 2011

Radionuclide and hybrid imaging of recurrent prostate cancer

scientific article published on 06 July 2010

Relationship of cell proliferation (Ki-67) to 99mTc-(V)DMSA uptake in breast cancer

artículo científico publicado en 2004

Restricted water diffusibility as measured by diffusion-weighted MR imaging and choline uptake in (11)C-choline PET/CT are correlated in pelvic lymph nodes in patients with prostate cancer

artículo científico publicado en 2011

Self-gated MRI motion modeling for respiratory motion compensation in integrated PET/MRI.

artículo científico publicado en 2014

Sensitivity of PET/MRI to detect recurrence of prostate cancer

artículo científico publicado en 2013

Simulation of a MR-PET protocol for staging of head-and-neck cancer including Dixon MR for attenuation correction

artículo científico publicado en 2011

Simultaneous (68)Ga-PSMA HBED-CC PET/MRI Improves the Localization of Primary Prostate Cancer.

artículo científico publicado en 2016

Systematic Comparison of the Performance of Integrated Whole-Body PET/MR Imaging to Conventional PET/CT for ¹⁸F-FDG Brain Imaging in Patients Examined for Suspected Dementia

artículo científico publicado en 2014

Tissue classification as a potential approach for attenuation correction in whole-body PET/MRI: evaluation with PET/CT data

artículo científico publicado en 2009

Value of a Dixon-based MR/PET attenuation correction sequence for the localization and evaluation of PET-positive lesions

artículo científico publicado en 2011

Workflow and scan protocol considerations for integrated whole-body PET/MRI in oncology

artículo científico publicado en 2012

[(11)C]Choline positron emission tomography/computed tomography for staging and restaging of patients with advanced prostate cancer

artículo científico publicado en 2008

[11C]Choline PET/CT in therapy response assessment of a neoadjuvant therapy in locally advanced and high risk prostate cancer before radical prostatectomy

artículo científico publicado en 2016

[11C]Choline as pharmacodynamic marker for therapy response assessment in a prostate cancer xenograft model

artículo científico publicado en 2010

Lista de obras de

11C-Choline PET/pathology image coregistration in primary localized prostate cancer

Categorical versus continuous circulating tumor cell enumeration as early surrogate marker for therapy response and prognosis during docetaxel therapy in metastatic prostate cancer patients

Comparison of [(11)C]Choline ([(11)C]CHO) and [(18)F]Bombesin (BAY 86-4367) as Imaging Probes for Prostate Cancer in a PC-3 Prostate Cancer Xenograft Model.

Comparison of [¹¹C]choline ([¹¹C]CHO) and S(+)-β-methyl-[¹¹C]choline ([¹¹C]SMC) as imaging probes for prostate cancer in a PC-3 prostate cancer xenograft model

Comparison of different SUV-based methods for response prediction to neoadjuvant radiochemotherapy in locally advanced rectal cancer by FDG-PET and MRI.

Comparison of integrated whole-body [11C]choline PET/MR with PET/CT in patients with prostate cancer

Detection of circulating tumor cells in different stages of prostate cancer

Diagnostic Efficacy of (68)Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate Cancer

Diagnostic value of retrospective PET-MRI fusion in head-and-neck cancer

Discrimination Between Brown and White Adipose Tissue Using a 2-Point Dixon Water-Fat Separation Method in Simultaneous PET/MRI.

Effective long-term treatment with bevacizumab for relapsed glioblastoma: case report and review of the literature

Evaluation of feasibility and image quality of 68Ga-DOTATOC positron emission tomography/magnetic resonance in comparison with positron emission tomography/computed tomography in patients with neuroendocrine tumors

Evaluation of the SUV values calculation and 4D PET integration in the radiotherapy treatment planning system ⬇️

FDG PET and PET/CT ⬇️

First clinical experience with integrated whole-body PET/MR: comparison to PET/CT in patients with oncologic diagnoses

Hypoxia imaging with FAZA-PET and theoretical considerations with regard to dose painting for individualization of radiotherapy in patients with head and neck cancer

Imaging gastric cancer with PET and the radiotracers 18F-FLT and 18F-FDG: a comparative analysis

Imaging in situ breast carcinoma (with or without an invasive component) with technetium-99m pentavalent dimercaptosuccinic acid and technetium-99m 2-methoxy isobutyl isonitrile scintimammography

Imaging of prostate cancer with PET/CT and radioactively labeled choline derivates ⬇️

Melanoma metastases to palatine tonsils obscured by physiological FDG uptake on PET/CT.

Motion correction strategies for integrated PET/MR.

Non-invasive assessment of inter-and intrapatient variability of integrin expression in metastasized prostate cancer by PET.

Non-invasive imaging of cardiac transgene expression with PET: comparison of the human sodium/iodide symporter gene and HSV1-tk as the reporter gene

PET-MRI fusion in head-and-neck oncology: current status and implications for hybrid PET/MRI.

PET/MR imaging in the detection and characterization of pulmonary lesions: technical and diagnostic evaluation in comparison to PET/CT.

PET/MR in Oncology: Non-18F-FDG Tracers for Routine Applications

PET/MR in prostate cancer: technical aspects and potential diagnostic value

Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions

Pretreatment 18F-FAZA PET predicts success of hypoxia-directed radiochemotherapy using tirapazamine

Prognostic value of 11C-choline PET/CT and CT for predicting survival of bladder cancer patients treated with radical cystectomy

Prognostic value of [18F]-fluoro-deoxy-glucose PET/CT, S100 or MIA for assessment of cancer-associated mortality in patients with high risk melanoma.

Radionuclide and hybrid imaging of recurrent prostate cancer

Relationship of cell proliferation (Ki-67) to 99mTc-(V)DMSA uptake in breast cancer

Restricted water diffusibility as measured by diffusion-weighted MR imaging and choline uptake in (11)C-choline PET/CT are correlated in pelvic lymph nodes in patients with prostate cancer

Self-gated MRI motion modeling for respiratory motion compensation in integrated PET/MRI.

Sensitivity of PET/MRI to detect recurrence of prostate cancer

Simulation of a MR-PET protocol for staging of head-and-neck cancer including Dixon MR for attenuation correction

Simultaneous (68)Ga-PSMA HBED-CC PET/MRI Improves the Localization of Primary Prostate Cancer.

Systematic Comparison of the Performance of Integrated Whole-Body PET/MR Imaging to Conventional PET/CT for ¹⁸F-FDG Brain Imaging in Patients Examined for Suspected Dementia

Tissue classification as a potential approach for attenuation correction in whole-body PET/MRI: evaluation with PET/CT data

Value of a Dixon-based MR/PET attenuation correction sequence for the localization and evaluation of PET-positive lesions

Workflow and scan protocol considerations for integrated whole-body PET/MRI in oncology

[(11)C]Choline positron emission tomography/computed tomography for staging and restaging of patients with advanced prostate cancer

[11C]Choline PET/CT in therapy response assessment of a neoadjuvant therapy in locally advanced and high risk prostate cancer before radical prostatectomy

[11C]Choline as pharmacodynamic marker for therapy response assessment in a prostate cancer xenograft model